Medscape
Two US Food and Drug Administration (FDA) advisory panels are urging the agency to eliminate the risk management program for the antipsychotic drug clozapine, saying that restrictions are limiting access to a life-changing and life-saving medication for people with schizophrenia. Members of the Drug Safety and Risk Management and Psychopharmacologic Drugs advisory committees held a …
Read More
Eliminate Clozapine REMS, FDA Panels Say
Lloyd Pecora
14:23
Two US Food and Drug Administration (FDA) advisory panels are urging the agency to eliminate the risk management program for the antipsychotic drug clozapine, saying that restrictions are limiting access to a life-changing and life-saving medication for people with schizophrenia. Members of the Drug Safety and Risk Management and Psychopharmacologic Drugs advisory committees held a
